← Nurses CPD
The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements for this session. Thank you for your cooperation and commitment to professional development.
PET Imaging & Targeted Therapies in Cancer: A Masterclass Series
SESSION ONE: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
The “PET Imaging & Targeted Therapies in Cancer” Masterclass Series is a unique and comprehensive educational series organized by the Sweden Ghana Medical Centre (SGMC) in partnership with Continuous Education Services (CES). This training program is designed to enhance healthcare professionals’ expertise in the use of PET (Positron Emission Tomography) imaging and advanced targeted therapies across various types of cancer. Participants will gain a deeper understanding of PET imaging’s critical role in cancer diagnosis, treatment planning, and patient monitoring, as well as the latest advancements in targeted therapies.
The series consists of five specialized sessions, each focusing on a specific cancer type and addressing its unique challenges and innovations in care. Each session will be led by highly qualified and experienced facilitators in oncology and medical imaging, bringing together theoretical insights and practical applications in an interactive format. The series will incorporate Q&A sessions to encourage in-depth discussions and ensure that participants gain actionable knowledge to apply in clinical practice.
SESSION BREAKDOWN
Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:
Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies
Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies
Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies
Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies
EARN CPD POINTS
Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.
WHY REGISTER AND ATTEND THIS TRAINING SERIES?
This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.
SESSION 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care
This foundational session explores the transformative impact of PET imaging on oncology, delving into its essential role in cancer diagnosis, treatment planning, and response monitoring. Participants will gain a comprehensive understanding of how PET scans have revolutionized the landscape of cancer care, offering a reliable and precise tool for detecting and assessing malignancies. Through an in-depth look at the science and application of PET imaging, this session will highlight its advantages and limitations, equipping participants with critical knowledge to leverage PET technology for enhanced patient outcomes.
ORGANIZED BY
PROUDLY SPONSORED BY
This virtual training will premier on Thursday the 14th of November 2024 at 4:00 PM.
Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists
Moderator: Dr. Amankwaa Frempong
Date: Thursday 14th November 2024
Time: 16:00 GMT (4:00 pm local time)
AGENDA
Thursday 14th November 2024 (VIRTUAL EVENT)
Overview
Course Description
The MASTERCLASS IN PET IMAGING & TARGETED THERAPIES FOR CANCER CARE begins with a foundational session, THE SIGNIFICANCE OF PET SCANS IN ONCOLOGY – A CORNERSTONE OF MODERN CANCER CARE. This session provides an in-depth exploration of how PET imaging has transformed oncology by enhancing the precision of cancer diagnosis, staging, treatment planning, and monitoring. Participants will gain a thorough understanding of the mechanisms behind PET technology and its unique ability to visualize metabolic activity in cancerous cells. Led by top experts in the field, this session also addresses the advantages and limitations of PET imaging, equipping attendees with practical insights to integrate PET into multidisciplinary cancer care for improved patient outcomes.
What you will learn
By the end of this session, participants will be able to:
1. Understand the fundamental role and applications of PET scans in oncology, including cancer diagnosis, staging, and treatment planning.
2. Comprehend the mechanism of PET imaging and how it visualizes metabolic activity within cancerous cells.
3. Assess the benefits and limitations of PET imaging in comparison with other imaging modalities in oncology.
4. Identify the ways PET scans support personalized treatment approaches and improve response monitoring.
5. Discuss the integration of PET imaging into multidisciplinary cancer care teams to enhance decision-making and patient outcomes.
Course Content
Lecture Sessions
- LIVE EVENT: Thursday 14th November 2024 from 1600 GMT (4:00 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitators
- 1 Course on CES
Dr. George Afari
BPharm, PharmD, MBA
Nuclear Pharmacist and Bioengineer
University of Ghana Medical Center, Accra
Dr. George Afari is a nuclear pharmacist and bioengineer with expertise in radiopharmaceutical manufacturing, computational biomedicine and biomanufacturing.
View full profile / courses
- 1 Course on CES
Dr. Emmanuel Nii Boye Hammond
MD, MMed (Nuclear Medicine), FCNP (SA), FGCP
Medical Superintendent || Specialist in Nuclear Medicine
Ghana Atomic Energy Commission (GAEC) Hospital || National Centre for Radiotherapy Oncology
and Nuclear Medicine (NCRONM) at the Korle-Bu Teaching Hospital, Accra.
Dr E.
View full profile / coursesRelated Courses
